Skip to main content
SEEGENE, INC. logo

SEEGENE, INC. — Investor Relations & Filings

Ticker · 096530 ISIN · KR7096530001 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2020-08-28 M&A Activity
Country KR South Korea
Listing KO 096530

About SEEGENE, INC.

https://www.seegene.com/

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Recent filings

Filing Released Lang Actions
주요사항보고서(유형자산양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding a decision to acquire tangible assets (real estate). This type of regulatory filing, which details specific corporate transactions or material events, falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to corporate mergers/acquisitions of entities) or capital changes.
2020-08-28 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Seegene, Inc.' covering the period from 2020.01.01 to 2020.06.30. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule report). It details changes in share ownership by the company's largest shareholder and related parties, including specific transaction dates, methods (e.g., market sales, gifts), and collateral agreements. This fits the definition of a 'Major Shareholding Notification' (MRQ) as it tracks significant ownership changes and thresholds.
2020-08-13 Korean
단기차입금증가결정
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding a decision to increase short-term borrowings (단기차입금증가결정). It details the amount, the purpose (stable fund management), and the board resolution date. This falls under corporate financing activities and capital structure changes, which aligns with the 'Capital/Financing Update' category.
2020-08-10 Korean
주요사항보고서(유형자산양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange by Seegene Inc. It details a specific corporate decision regarding the acquisition of tangible assets (real estate). This type of regulatory filing, which discloses significant corporate events or transactions that do not fall into specific categories like earnings or dividends, is best classified as a general regulatory filing.
2020-08-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details specific share transactions (disposals) made by an executive (Hwang In-taek) of Seegene Inc. This type of filing is a standard disclosure for insider trading/shareholding changes by company directors, which corresponds to the 'Director's Dealing' category.
2020-07-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.